This role, within the Interventional Oncology and Embolization division, is responsible for a wide variety of projects and regulatory strategy in early stage, new product development. This includes strategic support for Boston Scientific's TheraSphere products. This role provides an opportunity to gain regulatory experience in US, and EU, and other international regions. This is a hybrid position (in office minimum three days per week) based in Maple Grove, Minnesota (preferred) or Marlborough, MA.